MAPT and proteostasis deficiencies: Ultimately, comparative studies should clarify the role of peripheral immune responses in distinct proteinopathies and enable discovery of novel peripheral biomarkers that can successfully discriminate between tau and TDP-43 neuropathology, providing critical new tools for diagnostics and clinical trials.